Page last updated: 2024-10-25

nordazepam and Fibrosis

nordazepam has been researched along with Fibrosis in 1 studies

Nordazepam: An intermediate in the metabolism of DIAZEPAM to OXAZEPAM. It may have actions similar to those of diazepam.
nordazepam : A 1,4-benzodiazepinone having phenyl and chloro substituents at positions 5 and 7 respectively; it has anticonvulsant, anxiolytic, muscle relaxant and sedative properties but is used primarily in the treatment of anxiety.

Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.

Research Excerpts

ExcerptRelevanceReference
" administration the kinetics of total chlordesmethyldiazepam in patients with liver disease differed from those in controls: elimination half-life was almost twice that in controls (395 and 204 h), as a consequence of a marked reduction in total clearance (0."2.68Effects of liver disease on the pharmacokinetics of intravenous and oral chlordesmethyldiazepam. ( Bareggi, SR; Devis, G; Pirola, R; Potvin, P, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bareggi, SR1
Pirola, R1
Potvin, P1
Devis, G1

Trials

1 trial available for nordazepam and Fibrosis

ArticleYear
Effects of liver disease on the pharmacokinetics of intravenous and oral chlordesmethyldiazepam.
    European journal of clinical pharmacology, 1995, Volume: 48, Issue:3-4

    Topics: Administration, Oral; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Female; Fibrosis; Human

1995